Medicare Congress - The Leading Forum on Medicare Regulations and Compliance

Overview | Agenda/Speaker Materials | Continuing Education | Promotional Opportunities | Order CDs
Privacy Policy | Administration | Contact Us | Past Congress | Home


NATIONAL MEDICARE PRESCRIPTION DRUG CONGRESS

THE SECOND NATIONAL MEDICARE
PRESCRIPTION DRUG CONGRESS

The Leading Forum on the New Medicare Prescription Drug Coverage Legislation and Its Implications for Pharmaceutical Manufacturers, PBMs, Health Plans and Providers

L'Enfant Plaza Hotel
Washington, DC

October 31 - November 2, 2005



Powered by



Sponsored by















PLATINUM GRANTORS




SILVER GRANTORS


REGISTER TODAY FOR THE 2ND NATIONAL MEDICARE PRESCRIPTION DRUG CONGRESS

The Medicare Modernization Act has created the largest overhaul of the Medicare program since its inception. Medicare beneficiaries, pharmaceutical companies, managed care organizations (MCOs), pharmacy benefits managers (PBMs), state Medicaid programs, and providers all have the potential to shape the program. Join Avalere Health and thought leaders from each of these sectors for an engaging three-day session that will address critical questions about private health plan participation, benefit design, formulary practices, access to prescription drugs, and care for over 40 million Americans.

Keynote addresses will be provided by Tom Scully, Nancy-Ann DeParle, John Iglehart, and Dan Mendelson as well as several other current and former policymakers and representatives from the manufacturer, insurance, and PBM industries.

The conference will focus on:

  • Ways in which to market the new Part D benefit to beneficiaries,
  • The interplay between health plans, CMS, and USP in the development of formularies,
  • The operational challenges facing states and the ways in which states will address the challenges
  • Transferring dual eligible populations from Medicaid to Medicare
  • Marketplace response to new payment streams
  • The effect of the MMA on access to medications for beneficiaries in the long-term care setting
  • The MMA provisions related to the government role in adoption of health information technology
  • The potential impact of centralized data on prescription drug use patterns
  • The impact of the competitive acquisition program on beneficiaries and physicians














NOW AVAILABLE!
Purchase a CD-ROM which includes video of speakers with synced powerpoint presentations.

The Second National Medicare Prescription Drug Congress on CD-ROM

View the Second National Medicare Prescription Drug Congress plenary sessions video with synchronized PowerPoint slides and concurrent sessions audio on a CD-ROM from your computer. Instantly navigate to the presenter and the exact content you are after.

Ensure that your team's knowledge is current.

Click here for more details
and to order your copy today!

SUMMIT CO-CHAIRS:
Nancy-Ann DeParle
Senior Advisor, JPMorgan Partners, and Former Administrator, Health Care Financing Administration, Washington, DC

John Iglehart
Founding Editor, Health Affairs and National Correspondent, New England Journal of Medicine, Washington, DC

Dan Mendelson
President and Founder, Avalere Health, Former Associate Director for Health, Office of Management and Budget, Washington, DC

Thomas Scully
Senior Counsel, Alston & Bird, Senior Adviser, Welsh, Carson, Anderson and Stowe, and Former Administrator, Centers for Medicare and Medicaid Services, Department of Health & Human Services, Washington, DC


KEYNOTE SPEAKERS:
Alex M. Azar II
Deputy Secretary of the United States Department of Health and Human Services, US Department of Health and Human Services, Washington DC

David Brailer, MD, Ph.D.
National Health Information Technology Coordinator, Department of Health and Human Services, Washington, DC

Carolyn Clancy, MD
Director, Agency for Healthcare Research and Quality, Rockville, MD

Senator Chuck Grassley (R/IA)
Chairman of the Senate Finance Committee, United States Senate, Washington, DC

Karen Ignagni
Chief Executive Officer and President, America's Health Insurance Plans, Washington, DC

Mark B. McClellan, MD, Ph.D.
Administrator, Centers for Medicare and Medicaid Services, Former Commissioner, Food and Drug Administration, Washington, DC

Marion McCourt
Vice President, Government Affairs, Policy and Managed Markets, AstraZeneca, Wilmington, DE

Congressman Pete Stark (D-CA)
Ranking Democrat, Health Subcommittee, Ways and Means Committee, United States House of Representatives, Washington, DC

Dale Wolf
Chief Executive Officer, Coventry Health Care Inc., Bethesda, MD


FEATURED FACULTY:

Alexis Ahlstrom
Manager, Avalere Health, Washington, DC

W. Holt Anderson
Executive Director, North Carolina Healthcare Information and Communications Alliance, Inc., Research Triangle Park, NC

Gale Arden
Director, Disabled and Elderly Health Programs Group, Centers for Medicare and Medicaid Services, Washington, DC

Grant P. Bagley, MD, JD
Partner, Arnold & Porter, Former Director, Coverage and Analysis Group, HCFA Office of Clinical Standards and Quality, Washington, DC

Lauren Barnes
Manager, Avalere Health, Former U.S. Payment & Coverage Group Director (Amgen), Washington, DC

Sandra Bastinelli
Acting Director, Division of Special Programs, Center for Beneficiary Choices, Centers for Medicare and Medicaid Services, Baltimore, MD

Diana Birkett
Staff of the Finance Committee, United States Senate, Washington, DC

Jonathan Blum
Director of the Medicaid Practice, Avalere Health, Former Democratic Staff, Senate Finance Committee, Washington, DC

Charles Boorady
Managed Care Analyst, Smith Barney CitiGroup, New York, NY

Perry Bridger
Director, Avalere Health, Washington, DC

Pat Bousliman
Staff of the Finance Committee, United States Senate, Washington, DC

James Carey
Executive Director, Health Policy, Novartis Pharmaceuticals, East Hanover, NJ

Tanisha Carino, Ph.D.
Manager, Avalere Health, Washington, DC

Andrea Cohen
Medicare Rights Center, New York, NY

Kevin Concannon
Director, Iowa Department of Human Services, Des Moines, IA

John Coster, RPh, Ph.D.
Vice President of Policy and Programs, National Association of Chain Drug Stores, Washington, DC

Kelly Cronin
Centers for Medicare and Medicaid Services, Washington, DC

Susan S. de Mars, Esq.
Chief Legal Officer, United States Pharmacopeia, Rockville, MD

Colette Desmarais
Staff of the Finance Committee, United States Senate, Washington, DC

Bob Donnelly
Former Director, Medicare Drug Benefit Group, Center for Beneficiary Choices, Center for Medicare and Medicaid Services, Baltimore, MD

Sean M Dougherty
Senior Director, Medicare Strategy, Patient Assistance Programs, AstraZeneca, Wilmington, DE

Benjamin Edmands
Principal, JPMorgan Partners LLP, New York, NY

Sandra M. Foote
Director, Division of Chronic Care Improvement Programs, Centers for Medicare and Medicaid Services, Washington, DC

Richard Foster
Chief Actuary, Centers for Medicare and Medicaid Services, Washington, DC

Laurence J. Freedman, Esq.
Partner, Patton & Boggs, Former Assistant Director, Fraud Section, Commercial Litigation Branch, Civil Division, United States Department of Justice, Washington, DC

John Glaudemans
Managing Director, Avalere Health, Washington DC

Catherine C. Graeff, RPh, MBA
Senior Vice President, Communication and Industry Relations, National Council for Prescription Drug Programs, Scottsdale, AZ

Stuart Gutterman
Senior Program Director, Medicare's Future, The Commonwealth Fund, Washington, DC

Mark Hamelburg
Director, Employer Policy and Operations Group, Center for Beneficiary Choices, Centers for Medicare and Medicaid Services, Washington, DC

Kathleen Harrington
Director, Office of External Affairs, Centers for Medicare and Medicaid Services, Washington, DC

Cara Jareb, FSA, MAAA
Director of Retiree Medical Consulting, Watson Wyatt Worldwide, Arlington, VA

Missy Jenkins
Vice President, Federal Affairs, Pharmaceutical Care Management Association, Washington, DC

Congresswoman Nancy L. Johnson (R - CT) (Invited)
Chairwoman, Health Subcommittee, Ways and Means Committee, United States House of Representatives, Washington, DC

Jeffrey Kang, MD, MPH
Senior Vice President, Medical Strategy and Policy, Cigna Health Plans, Bloomfield, CT

Mike Kappel
Senior Vice President, Government Strategies and Programs, McKesson
San Francisco, CA


Daniel Kazzaz
President, Rapid Data Integration, Inc., Bethesda, MD

Mark Allen Kleiman, Esq.
Qui Tam Attorney, Law Offices of Mark Allen Kleiman, Los Angeles, CA

Shannah Koss
Director of Health Information Technology, Avalere, Washington, DC

Jane Kramer
Former Vice President, Public Affairs, Berlex, Montville, NJ

Karl Kurtz
Director, Idaho Department of Health & Welfare, Boise, ID

Jenifer Levinson
Director, Avalere Health, Washington, DC

Harvey Maldow, RPh, MS
Director, Professional Relations, AstraZeneca, Wilmington, DE

Stephen McConnell
Senior Vice President, Advocacy and Public Policy, The Alzheimer's Association, Chicago, IL

Mark McCullough
President, Kindred Pharmacy Services, Louisville, KY

Christopher McFadden
Healthcare Analyst, Goldman Sachs, New York, NY

Steve McMillan
Director, Government Reimbursement, AstraZeneca, Wilmington, DE

Dr. George Mensah
Acting Director, National Centers for Chronic Disease Prevention and Health Promotion, Washington DC

Mark Merritt
President, Pharmaceutical Care Management Association, Washington, DC

Mark Miller
Executive Director, Medicare Payment Advisory Commission, Washington, DC

Patrick Morrisey, Esq.
Partner, Sidley Austin Brown & Wood, Former Deputy Staff Director and Chief Health Counsel, Energy and Commerce Committee, United States House of Representatives, Washington, DC

Tricia Neuman, ScD
Director, Medicare Policy Project, Vice President, Kaiser Family Foundation, Washington, DC

Janet Newport
Vice President of Public Policy Programs, PacifiCare Health Systems, Inc., Cypress, CA

Tim Nugent
Director, Pharmaceutical Advisory Practice, PricewaterhouseCoopers, Florham Park, NJ

David Ogden
Senior Actuary, Milliman USA, Milwaukee, WI

Peter P. Parvis, Esq.
Partner, Venable LLP, Washington, DC

Janet Rehnquist, Esq.
Partner, Venable LLP, Former Inspector General, Department of Health and Human Services, Washington, DC

Scott Reid
Caremark, Nashville, TN

John Richardson
Director, Medicare Practice, Avalere Health, Washington, DC

Dean A. Rosen
Staff, Office of Majority Leader Bill Frist, United States Senate, Washington, DC

John Rother
Director of Policy and Strategy, AARP, Washington, DC

Phillip A. Rothermich
Vice President, Business Development, ExpressScripts Inc., Maryland Heights, MO

Amy Rousseau
Manager, Avalere Health, Washington, DC

Mark Rubino
Pharmacy Officer, Aetna, Hartford, CN

Donald R. Ryan
President and Chief Executive Officer, CareCore, Wappingers Falls, NY

Matt Salo
Legislative Director, Health, National Governors Association, Washington, DC

William A. Sarraille, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC

David Schulke
Executive Vice President, American Health Quality Association, Washington, DC

Kevin A. Schulman, MD
Professor of Medicine and Business Administration, Director, Center for Clinical and Genetic Economics, Vice Chair for Business Affairs, Department of Medicine, Duke University Medical Center, Durham, NC

John D. Shakow, Esq.
Counsel, King & Spalding LLP, Washington, DC

Jeffrey Shuren, MD, JD
Assistant Commissioner for Policy, Food and Drug Administration, Rockville, MD

Jean R. Slutsky
Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Washington, DC

Richard Smith
Senior Vice President, Policy & Research, Pharmaceutical Research & Manufacturers of America, Washington, DC

Tom Snedden
Director, Pennsylvania PACE/PACENet Programs, Harrisburg, PA

Francis Soistman
President, Health Plans, Coventry Health Care Inc., Bethesda, MD

Bruce Stuart, Ph.D.
Professor and Executive Director, Peter Lamy Center on Drug Therapy and Aging, University of Maryland, Baltimore, MD

Terri Swanson
General Manager, Part D, Cigna, Hartford, CT

Phyllis Torda
Vice President, Product Development, National Committee for Quality Assurance, Washington, DC

Leticia Van de Putte
Chair, Veteran Affairs and Military Installations Committee, Texas Senate, Co-Chair, Reforming States Group, San Antonio, TX

James M. Verdier, JD
Senior Fellow, Mathematica Policy Research, Inc., Washington, DC

Vikki Wachino
Director, Health Care, Center for Budget and Policy Priorities, Washington, DC

Sandeep Wadhwa, MD, MBA
Vice President of Care Management Services, McKesson Health Solutions, Broomfield, CO

Heidi Wagner
Senior Director, Government Affairs, Genentech, South San Francisco, CA

Chiquita White
Manager, Avalere Health, Washington, DC

Joel White
Staff of the Ways & Means Committee, United States House of Representatives, Washington, DC

Carrie Williams
Associate, Avalere Health, Washington, DC



We subscribe to the HONcode principles of the HON Foundation. Click to verify.


Overview | Agenda/Speaker Materials | Continuing Education | Promotional Opportunities | Order CDs
Privacy Policy | Administration | Contact Us | Past Congress | Home

All material on this website is protected by copyright.
Copyright @ 1999-2005 by Health Care Conference Administrators, LLC.
All rights reserved.

Contact Webmaster